December 7, 2022
The Pharmaceuticals and Medical Devices Agency (PMDA) said on December 6 that Eli Lilly’s ultra-fast acting insulin Lyumjev (insulin lispro) has obtained a label update regarding its use for the treatment of diabetes in children. In Japan, Lyumjev is approved...read more